Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic...

por Takeuchi, Tsutomu, Matsubara, Tsukasa, Urata, Yukitomo, Suematsu, Eiichi, Ohta, Shuji, Honjo, Shigeru, Abe, Tohru, Yamamoto, Ami, Miyasaka, Nobuyuki
Publicado 2014

SNP algorithms for prediction of efficacy and adverse events of abatacept (ABT)

por Middleton, James E, Matsubara, Tsukasa, Funahashi, Keiko, Koyano, Satoru, Hagiwara, Takafumi, Miura, Takako, Okuda, Kosuke, Nakamura, Takeshi, Iwahashi, Mitsuyoshi, Tsuru, Tomomi, Uchimura, Shoichi, Honjo, Shigeru
Publicado 2012

Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis

por Ohmura, Koichiro, Terao, Chikashi, Maruya, Etsuko, Katayama, Masaki, Matoba, Kenichiro, Shimada, Kota, Murasawa, Akira, Honjo, Shigeru, Takasugi, Kiyoshi, Tohma, Shigeto, Matsuo, Keitaro, Tajima, Kazuo, Yukawa, Naoichiro, Kawabata, Daisuke, Nojima, Takaki, Fujii, Takao, Yamada, Ryo, Saji, Hiroo, Matsuda, Fumihiko, Mimori, Tsuneyo
Publicado 2010

ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese

por Terao, Chikashi, Ohmura, Koichiro, Ikari, Katsunori, Kochi, Yuta, Maruya, Etsuko, Katayama, Masaki, Yurugi, Kimiko, Shimada, Kota, Murasawa, Akira, Honjo, Shigeru, Takasugi, Kiyoshi, Matsuo, Keitaro, Tajima, Kazuo, Suzuki, Akari, Yamamoto, Kazuhiko, Momohara, Shigeki, Yamanaka, Hisashi, Yamada, Ryo, Saji, Hiroo, Matsuda, Fumihiko, Mimori, Tsuneyo
Publicado 2012